Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural requirements for PAK activation by Rac GTPases

U G Knaus1, Y Wang, A M Reilly

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA. uknaus@scripps.edu

The Journal of Biological Chemistry
|August 15, 1998
PubMed
Summary

Differences in the C-terminal polybasic domains of Rac1 and Rac2 explain their distinct abilities to activate p21-activated kinase (PAK). This suggests Rac

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatal Errors.

The Homoeopathic physician·2023
Same author

Fatal Errors.

The Homoeopathic physician·2023
Same author

Some Clinical Experience.

The Homoeopathic physician·2023
Same author

An Instructive Lesson.

The Homoeopathic physician·2023
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.

QJM : monthly journal of the Association of Physicians·2017

Area of Science:

  • Molecular and Cellular Biology
  • Signal Transduction
  • Protein-Protein Interactions

Background:

  • Rho family GTPases, including Rac1 and Rac2, are crucial regulators of cellular processes like cytoskeletal dynamics and cell cycle progression.
  • p21-activated kinases (PAKs) are key downstream effectors implicated in mediating cellular functions regulated by Rac and Cdc42 GTPases.
  • Understanding the specific interactions between Rac isoforms and PAK is essential for deciphering their distinct roles in normal and disease states.

Purpose of the Study:

  • To elucidate the structural basis for differential activation of PAK1 by Rac1 and Rac2.
  • To identify specific domains within Rac and PAK proteins critical for their binding and kinase activity regulation.
  • To investigate the role of C-terminal polybasic domains in Rac and basic regions in PAK in mediating effector interactions.

Related Experiment Videos

Main Methods:

  • Utilized mutational analysis to probe the functional significance of specific amino acid residues in Rac and PAK.
  • Assessed protein binding affinities between Rac isoforms and PAK1 using biochemical assays.
  • Quantified PAK1 kinase activity in response to different Rac variants and mutants.

Main Results:

  • Rac1 exhibited significantly higher binding affinity and kinase activation of PAK1 compared to Rac2.
  • Mutations in the C-terminal polybasic domain of Rac1 drastically reduced PAK1 binding and activation, with domain swapping reversing these properties between Rac1 and Rac2.
  • A basic region (Lys66-Lys67-Lys68) in PAK was identified as essential for efficient binding and activation by Rac and Cdc42, with specific mutations altering these interactions.

Conclusions:

  • Differences in the C-terminal polybasic domains of Rac1 and Rac2 are the primary determinants of their distinct abilities to activate PAK.
  • The polybasic domain of Rac represents a novel effector-binding interface, potentially enabling isoform-specific signaling.
  • A basic region within PAK is critical for kinase activation, and mere binding of Rac/Cdc42 is insufficient for full activation.